Agaasimaha Guud ee Teva: Suuqa Daawada Cudurka Jinsiga ee Schizophrenia wuxuu leeyahay $2 Bilyan oo Potensiyaal Sanadle ah
Teva Pharmaceuticals CEO Richard Francis ayaa saadaaliyay in daawooyinka loo qaadanayo cudurka schizophrenia ay sannadkii soo saari doonaan $1.5 ilaa $2 bilyan oo doolar, kadib markii hay'adda FDA ay ansixisay WELTRUZA.